NCT07494253Enrolling by invitation
Effects of Mulberry Leaf Extract Formulation on Postprandial Glycemic Levels in Obese Children and Adolescents
Effects of Mulberry Leaf Extract Formulation on Postprandial Glycemic Levels in Obese Children and Adolescents: A Pilot Study (PEDRED)
Source: ClinicalTrials.gov · Last updated 22 Jun 2026
Brief summary (registry, in English)
The study entitled "Effects of mulberry leaf extract formulationon Postprandial Glycemic Peak in Obese Children and Adolescents: A Pilot Study" aims to evaluate the improvement in glycemic and insulinemic levels produced by a food supplement extracted from white mulberry (Morus alba), after 12 weeks of treatment in a cohort of obese children and adolescents. Clinical and anthropometric data (age, sex, weight, height, BMI, pubertal stage) will be collected, along with data from blood chemistry tests performed during routine follow-up visits, in accordance with Good Clinical Practice guidelines.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 12 Mar 2026
- Start date
- 1 Jun 2025
- Primary completion date
- 12 Jan 2026
- Lead sponsor
- University of Bari Aldo Moro
- Diseases
- Obesity
- NCT number
- NCT07494253
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 1 Jun 2025 to the primary completion date, 12 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- chronic use of steroid drugs
Other illness
- diagnosis of type 1 diabetes
- known allergies or hypersensitvity to any component of the stusy product (Reducose)
Lab values
- use of medications known to affect glucose metabolism
Who the study is looking for
- Body mass index (BMI) \>95° percentile for age and sex, according to WHO growth standards
- absence of chronic deseases
Age in the registry: 6 years to 16 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ospedale Pediatrico Giovanni XXIII Coordinator of this site? Confirm its status | Bari | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.